Advertisement

Topics

Geron CEO Steps Down

13:08 EST 9 Feb 2011 |

Geron (NASDAQ: GERN) said today that CEO Thomas Okarma has left the company as president, CEO, and as a member of the board of directors. The Menlo Park, CA-based developer of stem cell therapies said David Greenwood, the company’s chief financial officer, will step up as president and interim CEO, and will take a board [...]

Original Article: Geron CEO Steps Down

NEXT ARTICLE

More From BioPortfolio on "Geron CEO Steps Down"

Advertisement
Quick Search
Advertisement
Advertisement